{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:49:21Z","timestamp":1791866961296,"version":"4.3.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Melatonin is considered a safe OTC sleep aid with rarely reported adverse effects despite limited data. We present a case of acute orolingual choreoathetosis and auditory hallucinations following 132\u00a0mg ingestion of melatonin in an otherwise healthy, 22-year-old active-duty male in IBOLC training. The patient developed abrupt, predominantly orolingual choreoathetosis and mild auditory hallucinations, 1 hour after waking. Three days earlier, he began taking 24 mg of melatonin nightly for insomnia and ingested 132 mg the night before presentation. He denied alcohol, illicit drug, or other medication use. On ED arrival, he was hemodynamically stable with continuous orolingual choreoathetosis. Initial labs demonstrated mild acute kidney injury and transaminitis. Head CT was unremarkable. MRI head showed a nonspecific left frontal white matter hyperintensity. Lumbar puncture revealed normal protein and WBC, negative culture, and negative oligoclonal bands, though CSF processing difficulties prevented autoimmune panel completion. Neurologic symptoms resolved by the next morning without recurrence, and a subsequent EEG was unremarkable. This case documents a temporal association between high-dose melatonin exposure and acute neurologic symptoms but does not establish melatonin as the cause. The clinical presentation also occurred in the setting of substantial confounders, including sleep deprivation and heat exposure. This observation supports further investigation of uncommon neurologic presentations occurring after high-dose melatonin intake.<\/jats:p>","DOI":"10.1093\/milmed\/usag468","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:44:48Z","timestamp":1790682288000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Onset Orolingual Choreoathetosis and Auditory Hallucinations in a Healthy Young Adult Following High Melatonin Dose"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4246-6124","authenticated-orcid":false,"given":"Hunter L","family":"Bain","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Martin Army Community Hospital , Fort Benning, GA 31905,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6002-1295","authenticated-orcid":false,"given":"Alexandra M","family":"Yanez","sequence":"additional","affiliation":[{"name":"Medical school, Uniformed Services University of the Health Sciences , Bethesda, MD 20814,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8828-0347","authenticated-orcid":false,"given":"Samuel I","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Martin Army Community Hospital , Fort Benning, GA 31905,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2026101300401920000_usag468-B1","doi-asserted-by":"publisher","first-page":"EVIDra2400096","DOI":"10.1056\/EVIDra2400096","article-title":"Sleep disorders","volume":"3","author":"Robbins","year":"2024","journal-title":"NEJM Evid"},{"key":"2026101300401920000_usag468-B2","doi-asserted-by":"publisher","first-page":"102121","DOI":"10.1016\/j.smrv.2025.102121","article-title":"Estimation of the global prevalence and burden of insomnia: a systematic literature review-based analysis","volume":"82","author":"Benjafield","year":"2025","journal-title":"Sleep Med Rev"},{"key":"2026101300401920000_usag468-B3","doi-asserted-by":"publisher","DOI":"10.30521\/statpearls","volume-title":"Melatonin","author":"Savage","year":"2024"},{"key":"2026101300401920000_usag468-B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2021.23652","article-title":"Trends in use of melatonin supplements among US adults, 1999-2018","volume":"327","author":"Li","year":"2022","journal-title":"JAMA"},{"key":"2026101300401920000_usag468-B5","doi-asserted-by":"publisher","first-page":"e12782","DOI":"10.1111\/jpi.12782","article-title":"Safety of higher doses of melatonin in adults: a systematic review and meta-analysis","volume":"72","author":"Menczel Schrire","year":"2022","journal-title":"J Pineal Res"},{"key":"2026101300401920000_usag468-B6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11325-025-03331-1","article-title":"Melatonin supplementation: new insights into health and disease","volume":"29","author":"Minari","year":"2025","journal-title":"Sleep Breath"},{"key":"2026101300401920000_usag468-B7","first-page":"334","article-title":"Seguridad en el uso de la melatonina","volume":"29","author":"Morera","year":"2001","journal-title":"Actas Esp Psiquiatr"},{"key":"2026101300401920000_usag468-B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0022-3565(25)22029-8","article-title":"Psychopharmacological effects of melatonin in mouse and rat","volume":"227","author":"Sugden","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"2026101300401920000_usag468-B9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/pharmaceutics16070871","article-title":"Development, characterization, and evaluation of potential systemic toxicity of a novel oral melatonin formulation","volume":"16","author":"Cheaburu-Yilmaz","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026101300401920000_usag468-B10","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.sleepx.2024.100116","article-title":"Case report on melatonin overdose: cause and concern","volume":"7","author":"Tripathi","year":"2024","journal-title":"Sleep Med X"},{"key":"2026101300401920000_usag468-B11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content","volume":"13","author":"Erland","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"2026101300401920000_usag468-B12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/tx970202h","article-title":"Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome","volume":"11","author":"Williamson","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"2026101300401920000_usag468-B13","doi-asserted-by":"publisher","DOI":"10.30521\/statpearls","volume-title":"Chorea","author":"Lui","year":"2026"},{"key":"2026101300401920000_usag468-B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11011-012-9307-9","article-title":"Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects","volume":"27","author":"Anderson","year":"2012","journal-title":"Metab Brain Dis"},{"key":"2026101300401920000_usag468-B15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.15585\/mmwr.mm7122a1","article-title":"Pediatric melatonin ingestions\u2013United States, 2012-2021","volume":"71","author":"Lelak","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026101300401920000_usag468-B16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-c","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"2026101300401920000_usag468-B17","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.18.643990","article-title":"A corticostriatal learning mechanism linking excess striatal dopamine and auditory hallucinations","author":"Lakshminarasimhan","year":"2025","journal-title":"bioRxiv"},{"key":"2026101300401920000_usag468-B18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/jcem-61-6-1214","article-title":"Pharmacokinetics of melatonin in man: first pass hepatic metabolism","volume":"61","author":"Lane","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101300401920000_usag468-B19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1034\/j.1600-079x.2001.310408.x","article-title":"Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices","volume":"31","author":"Skene","year":"2001","journal-title":"J Pineal Res"},{"key":"2026101300401920000_usag468-B20","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/ijms15022538","article-title":"Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism","volume":"15","author":"Dixon","year":"2014","journal-title":"Int J Mol Sci"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag468\/71889138\/usag468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag468\/71889138\/usag468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:40:32Z","timestamp":1791866432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article\/doi\/10.1093\/milmed\/usag468\/8911594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1093\/milmed\/usag468","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"article-number":"usag468"}}